clinical trials

Sanofi/Regeneron’s Dupixent shows more promise in nasal polyps
Pharmaforum
Tue, 02/26/19 - 11:48 pm
Sanofi
Regeneron
Dupixent
clinical trials
nasal polyps
AstraZeneca, Merck notch another major Lynparza trial win — this time in pancreatic cancer
Endpoints
Tue, 02/26/19 - 09:34 am
AstraZeneca
Merck
pancreatic cancer
clinical trials
BRCA-mutated prostate cancer
Can Roche’s little tech startup help the FDA change clinical trials?
Stat
Mon, 02/25/19 - 11:34 pm
FDA
Roche
clinical trials
Flatiron Health
AstraZeneca's clot-fighter Brilinta shows promise in diabetics with heart disease in big study
Endpoints
Mon, 02/25/19 - 09:50 am
AstraZeneca
Brilinta
diabetes
blood thinner
clinical trials
Intercept stock drop reflects the high bar set for NASH drugs
BioPharma Dive
Sat, 02/23/19 - 04:52 pm
Intercept Pharma
Ocaliva
NASH
clinical trials
40 Sites Across The Country To Test New Alzheimer's Drug
Forbes
Wed, 02/20/19 - 06:01 pm
clinical trials
Alzheimer's disease
troriluzole
Biohaven
Merck’s PhIII liver cancer study for Keytruda fails on two key endpoints, just three months after the FDA gave it the green light
Endpoints
Tue, 02/19/19 - 07:48 pm
Merck
Keytruda
clinical trials
liver cancer
Intercept Pharma is One Step Closer to Filing for Approval of First NASH Treatment
BioSpace
Tue, 02/19/19 - 10:24 am
NASH
Intercept Pharmaceuticals
obeticholic acid
OCA
clinical trials
Higher dose of Pfizer-Lilly drug helps reduce back pain in study
Yahoo/Reuters
Tue, 02/19/19 - 09:54 am
Pfizer
Eli Lilly
chronic low back pain
low back pain
clinical trials
tanezumab
opioid alternatives
Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride
Pharmaceutical Business Review
Fri, 02/15/19 - 10:13 am
Boehringer Ingelheim
Eli Lilly
glimepiride
linagliptin
Tradjenta
type 2 diabetes
clinical trials
Merck plans trio of Phase 3 Keytruda studies in prostate cancer
BioPharma Dive
Thu, 02/14/19 - 05:56 pm
Merck
Keytruda
prostate cancer
clinical trials
Boehringer Ingelheim and IBM link up for blockchain-powered clinical trials in Canada
Fierce Biotech
Tue, 02/12/19 - 12:03 pm
Boehringer Ingelheim
IBM
Canada
blockchain
clinical trials
Interview: Clinical Trial Transparency Is Improving, Particularly Among Larger Companies
BioSpace
Tue, 02/12/19 - 09:34 am
clinical trials
clinical trial transparency
transparency
Asco-GU – Bristol’s renal cancer lead looks to be short-lived
EP Vantage
Mon, 02/11/19 - 08:24 pm
renal cell carcinoma
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
clinical trials
Sutent
It's a flop: Gilead's top late-stage drug selonsertib flunked its first Phase III NASH trial
Endpoints
Mon, 02/11/19 - 08:06 pm
Gilead Sciences
NASH
selonsertib
clinical trials
Here's Why Sage Therapeutics Gained 48.9% in January
Motley Fool
Sun, 02/10/19 - 11:04 pm
SAGE Therapeutics
SAGE-217
postpartum depression
clinical trials
Sangamo Sinks Most in a Decade as Gene-Editing Study Fizzles
Bloomberg
Thu, 02/7/19 - 03:30 pm
Sangamo BioSciences
clinical trials
gene editing
CRIPSR
MPS II
Solid Bio is hit by another setback as initial biopsies spotlight a flop for Duchenne MD
Endpoints
Thu, 02/7/19 - 09:37 am
Solid Biosciences
clinical trials
Duchenne Muscular Dystrophy
SGT-001
Rare pediatric PRV program not linked to uptick in new drugs starting trials, study finds
Forbes
Thu, 02/7/19 - 09:54 am
FDA
clinical trials
priority review vouchers
pediatrics
pediatric rare diseases
Takeda's Hemophilia A Drug: New Data and a $155 Million Patent Infringement Settlement
BioSpace
Wed, 02/6/19 - 11:17 am
Takeda
clinical trials
Adynovate
Baxalta
Bayer
patents

Pages